NextPlat (NASDAQ:NXPL) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of NextPlat (NASDAQ:NXPL) to a hold rating in a research report sent to investors on Saturday.

A number of other brokerages have also recently commented on NXPL. Litchfield Hills Research began coverage on NextPlat in a research report on Wednesday, June 24th. They set a “buy” rating and a $11.00 price target for the company. Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research note on Friday, August 7th. Finally, Zacks Research raised NextPlat to a “hold” rating in a report on Thursday, June 25th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $11.00.

NextPlat Trading Down 0.2%

Shares of NextPlat stock opened at $9.13 on Friday. The firm’s 50 day simple moving average is $6.71 and its two-hundred day simple moving average is $6.04. The firm has a market capitalization of $24.77 million, a price-to-earnings ratio of -2.49 and a beta of 1.83. NextPlat has a 12-month low of $3.38 and a 12-month high of $11.10. The company has a current ratio of 2.29, a quick ratio of 1.92 and a debt-to-equity ratio of 0.05.

NextPlat (NASDAQ:NXPL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.16. NextPlat had a negative net margin of 20.38% and a negative return on equity of 54.66%. The business had revenue of $11.88 million during the quarter, compared to the consensus estimate of $11.00 million. Analysts predict that NextPlat will post -0.85 EPS for the current year.

Institutional Investors Weigh In On NextPlat

An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in shares of NextPlat Corp. (NASDAQ:NXPL) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.